SXTPW
60 Degrees Pharmaceuticals Inc. Warrant
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$0.000
Kõrge
$0.000
Madal
$0.000
Maht
0.00M
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika
Seotud uudised
Babesiosis Incidence in U.S. 10x Higher Than CDC Estimates, According to Insurance Claims Study Commissioned by 60 Degrees Pharmaceuticals
25,000 U.S. adults per year claim reimbursement for medical costs associated with babesiosis v. CDC estimates of 2,000A full 45 percent of persistent babesiosis cases include chronic fatigueHealthcare providers treating
60 Degrees Pharmaceuticals Announces First Quarter 2025 Results
Q1 2024 net product revenues increased 55% year-over-year to $163.6 thousand.Gross profit increased 124% to $90.3 thousand. WASHINGTON, May 15, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP;
Seotud aktsiad
OCEAW
Ocean Biomediacal Inc. Warrants
MBNKP
Medallion Bank Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock Series F
CLOV
Clover Health Investments Corp.
PRLHU
Pearl Holdings Acquisition Corp Unit
HOFVW
Hall of Fame Resort & Entertainment Company Warrant
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.